HK1045939B - Lim礦化蛋白接合變體 - Google Patents

Lim礦化蛋白接合變體

Info

Publication number
HK1045939B
HK1045939B HK02106282.2A HK02106282A HK1045939B HK 1045939 B HK1045939 B HK 1045939B HK 02106282 A HK02106282 A HK 02106282A HK 1045939 B HK1045939 B HK 1045939B
Authority
HK
Hong Kong
Prior art keywords
lim mineralization
mineralization protein
nucleic acid
isolated nucleic
vectors
Prior art date
Application number
HK02106282.2A
Other languages
English (en)
Other versions
HK1045939A1 (en
Inventor
Scott D Boden
Gregory A Hair
Original Assignee
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Emory filed Critical Univ Emory
Publication of HK1045939A1 publication Critical patent/HK1045939A1/xx
Publication of HK1045939B publication Critical patent/HK1045939B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK02106282.2A 1999-04-30 2002-08-26 Lim礦化蛋白接合變體 HK1045939B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13202199P 1999-04-30 1999-04-30
PCT/US2000/011664 WO2000066178A1 (en) 1999-04-30 2000-04-28 Lim mineralization protein splice variants

Publications (2)

Publication Number Publication Date
HK1045939A1 HK1045939A1 (en) 2002-12-20
HK1045939B true HK1045939B (zh) 2007-10-05

Family

ID=22452079

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02106282.2A HK1045939B (zh) 1999-04-30 2002-08-26 Lim礦化蛋白接合變體

Country Status (13)

Country Link
US (2) US7045614B1 (zh)
EP (2) EP1808182A1 (zh)
JP (1) JP4615736B2 (zh)
KR (1) KR100697403B1 (zh)
CN (2) CN100441688C (zh)
AT (1) ATE363918T1 (zh)
AU (1) AU765516B2 (zh)
CA (1) CA2372192A1 (zh)
DE (1) DE60035107T2 (zh)
ES (1) ES2288474T3 (zh)
HK (1) HK1045939B (zh)
NZ (1) NZ515584A (zh)
WO (1) WO2000066178A1 (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7741117B2 (en) * 1997-04-30 2010-06-22 Emory University Bone mineralization protein expression systems, and methods of studying intracellular signaling pathways induced thereby
US7923250B2 (en) * 1997-07-30 2011-04-12 Warsaw Orthopedic, Inc. Methods of expressing LIM mineralization protein in non-osseous cells
JP4302877B2 (ja) * 1997-07-30 2009-07-29 エモリー・ユニバーシテイ 新規な骨鉱化蛋白質、ｄｎａ、ベクター及び発現系
US20030225021A1 (en) * 2001-11-14 2003-12-04 Mckay William F. Methods of inducing the expression of bone morphogenetic proteins (BMPs) and transforming growth factor-beta proteins (TGF-betas) in cells
US8916691B2 (en) * 1998-07-29 2014-12-23 Warsaw Orthopedic, Inc. Methods of expressing LIM mineralization protein
EP1242577B1 (en) * 1999-12-28 2008-04-16 The Regents Of The University Of Michigan Process for ex vivo formation of mammalian bone and uses thereof
US6811776B2 (en) 2000-12-27 2004-11-02 The Regents Of The University Of Michigan Process for ex vivo formation of mammalian bone and uses thereof
JP2004536794A (ja) * 2001-04-09 2004-12-09 メドトロニック、インコーポレイテッド マイクロ遠心機を用いる血液成分の分離方法及びその使用法
US7781574B2 (en) * 2001-11-14 2010-08-24 Emory University Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof
JP2007505621A (ja) * 2004-04-13 2007-03-15 メドトロニック・ソファモア・ダネック 骨誘導タンパク質及びペプチドの細胞内送達
JP2008538111A (ja) * 2005-03-22 2008-10-09 ウォーソー・オーソペディック・インコーポレーテッド Ｌｉｍミネラル化タンパク質−１（ｌｍｐ−１）による骨誘導の機構
WO2008156500A2 (en) * 2006-11-21 2008-12-24 Warsaw Orthopedic, Inc. Methods of inducing or increasing the expression of proteoglycans such as aggrecan in cells
US20090110637A1 (en) * 2007-10-26 2009-04-30 Warsaw Orthopedic, Inc. LMP and Regulation of Tissue Growth
JP5878477B2 (ja) 2010-01-15 2016-03-08 ユニバーシティ オブ メディスン アンド デンティストリー オブ ニュー ジャージー 骨の治癒を加速するためのバナジウム化合物の使用
US20140322292A1 (en) 2010-12-10 2014-10-30 Rutgers, The State University Of New Jersey Insulin-mimetics as therapeutic adjuncts for bone regeneration
WO2013006798A1 (en) 2011-07-06 2013-01-10 University Of Medicine And Dentistry Of New Jersey Vandium compounds as therapeutic adjuncts for cartilage regeneration and repair
CA2827392A1 (en) 2011-02-24 2012-08-30 Emory University Noggin blocking compositions for ossification and methods related thereto
US20140248372A1 (en) 2011-09-19 2014-09-04 Emory University Bone morphogenetic protein pathway activation, compositions for ossification, and methods related thereto
EP2785358B1 (en) * 2011-11-29 2022-06-01 Rutgers, the State University of New Jersey Insulin-mimetics as therapeutic adjuncts for bone regeneration
US20150148292A1 (en) 2012-07-09 2015-05-28 Emory University Bone morphogenetic protein pathway activation, compositions for ossification, and methods related thereto

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4302877B2 (ja) 1997-07-30 2009-07-29 エモリー・ユニバーシテイ 新規な骨鉱化蛋白質、ｄｎａ、ベクター及び発現系

Also Published As

Publication number Publication date
ATE363918T1 (de) 2007-06-15
US20070116689A1 (en) 2007-05-24
KR20020033615A (ko) 2002-05-07
DE60035107D1 (de) 2007-07-19
CN1908170A (zh) 2007-02-07
KR100697403B1 (ko) 2007-03-20
CN100441688C (zh) 2008-12-10
JP2002542802A (ja) 2002-12-17
US7045614B1 (en) 2006-05-16
ES2288474T3 (es) 2008-01-16
NZ515584A (en) 2005-03-24
CN1315537C (zh) 2007-05-16
CA2372192A1 (en) 2000-11-09
CN1355714A (zh) 2002-06-26
AU4683100A (en) 2000-11-17
JP4615736B2 (ja) 2011-01-19
WO2000066178A1 (en) 2000-11-09
AU765516B2 (en) 2003-09-18
WO2000066178A9 (en) 2001-03-15
HK1045939A1 (en) 2002-12-20
EP1181056A1 (en) 2002-02-27
EP1181056B1 (en) 2007-06-06
US7517866B2 (en) 2009-04-14
DE60035107T2 (de) 2007-09-27
EP1181056A4 (en) 2003-04-16
EP1808182A1 (en) 2007-07-18

Similar Documents

Publication Publication Date Title
ATE417927T1 (de) Neue knochenmineralisierungsproteine, dna, vektoren, expressionssysteme
HK1045939A1 (en) Lim mineralization protein splice variants
Nomura Bacterial ribosome
DE60042969D1 (de) Zubereitungen und methoden zur verwendung in rekombinatorischem klonen von nukleinsäuren
ES2177475T1 (es) Genes de corynebacterium glutamicum que codifican proteinas de una ruta metabolica.
AP1678A (en) Novel modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems.
EP1798239A3 (en) G-protein coupled receptors and uses therefor
DK0973928T3 (da) DNA-baseret transposonsystem til indføring af nukleinsyre i DNA i en celle
HUP0203340A2 (hu) Stressz-, rezisztencia- és toleranciafehérjéket kódoló Corynebacterium glutamicum gének
DK0489058T3 (da) Cystisk fibrose gen
ATE315087T1 (de) Neuartige auf p53 ansprechende gene
WO2000003685A3 (en) Nitrilase homologs
AU7599500A (en) Novel gl50 molecules and uses therefor
DK1446489T3 (da) Intakte miniceller som vektorer for DNA-overførsel og genterapi in vitro og in vivo
WO2003042368A3 (en) Methods of expressing lim mineralization protein in non-osseous cells
BR9809433A (pt) Moléculas de dna enzimáticas
WO2001000842A3 (en) Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation
AU2390301A (en) Corynebacterium glutamicum genes encoding metabolic pathway proteins
ATE310085T1 (de) Cyclin-e2 proteine und dafür kodierende gene
WO2005023996A3 (en) METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-β PROTEINS (TGF-βs) IN CELLS
WO2002066636A3 (en) T cell receptor variants expressed in mesenchymal cells and uses thereof
WO2002074960A3 (en) 38650, 28472, 5495, 65507, 81588 and 14354 methods and compositions of human proteins and uses thereof
AU2001253258A1 (en) Human trp-like calcium channel protein-2 (tlcc-2)
WO2001053470A3 (en) Nucleic acid and amino acid sequences encoding a de novo dna methyltransferase
WO2002006485A3 (en) 47885, a novel human ubiquitin-activating enzyme and uses therefor

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110428